Defying today’s challenging funding landscape, healthtech startup Level Zero Health has announced a £5.5 ($6.9) million pre-seed funding round spearheaded by leading European VC, redalpine, to enable remote and continuous hormone monitoringusing first-of-their-kind DNA-based sensors. HAX (SOSV), Entrepreneur First, and industry experts also contributed to the round.